FindTrial
Sign In

Expression Of MUCIN-4 In Laryngeal Squamous Cell Cancer

Expression Of MUCIN-4 In Laryngeal Squamous Cell Carcinoma - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/066931
Enrollment
40
Registered
2024-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C32- Malignant neoplasm of larynx

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Maulana Azad Medical College and Associated Lok Nayak Hospital
Lead Sponsor
Dr H C TANEJA
Collaborator
Dr P K RATHORE
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All histologically confirmed patients of Laryngeal Squamous Cell Carcinoma will be included in the study.

Exclusion criteria

Exclusion criteria: Patients who have received any previous treatment in the form of surgery, radiation and chemotherapy.

Design outcomes

Primary

MeasureTime frame
Proportion of patients expressing MUC-4 in Laryngeal Squamous Cell Carcinoma.Timepoint: at baseline, 8 weeks & 1 year—

Secondary

MeasureTime frame
Statistical significance between MUC-4 expression in Laryngeal Squamous Cell Carcinoma & neck metastasis.Timepoint: at baseline, 8 weeks & 1 year—

Countries

India

Contacts

Public ContactDr H C Taneja

Maulana Azad Medical College, Lok Nayak Hospital

taneja_hc@yahoo.com919868399555

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026